2m 2m 2m 2m 2m 2m 2m
TRANSMEDICS GRP (TMDX)
NASDAQ
$74.28-$1.23 (-1.64%)
Price as of Jun 23, 2026 7:52 PM EDT- $2.6BMarket Cap
- -40.79%1-Year Change
- Medical DevicesIndustry
TRANSMEDICS GRP (TMDX)
$74.28-$1.23 (-1.64%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 372.4M -15.66% | 441.5M +82.74% | 241.6M +158.53% | 93.5M +208.83% | |
Cost of Revenue | 77.8M -56.64% | 179.5M +105.03% | 87.5M +210.53% | 28.2M +209.65% | |
Gross Profit | 362.8M +38.43% | 262.1M +70.08% | 154.1M +136.08% | 65.3M +208.48% | |
Sales and Marketing Expense | 185.2M +9.82% | 168.6M +41.04% | 119.6M +71.04% | 69.9M +82.58% | |
Research and Development Expense | -69.1M +23.38% | -56.0M +55.23% | -36.1M +34.47% | -26.8M +20.21% | |
Depreciation and Amortization Expense | 27.2M +37.59% | 19.8M +141.63% | 8.2M +135.11% | 3.5M +91.41% | |
Total Operating Expenses | 254.2M +13.20% | 224.6M +22.84% | 182.8M +89.04% | 96.7M +59.62% | |
Operating Profit | 108.6M +189.59% | 37.5M +230.53% | -28.7M -8.62% | -31.4M -20.27% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -9.8M +1.03% | -9.7M -10.11% | -10.8M +189.61% | -3.7M -3.82% | |
Interest Income and Expense and Net | -9.8M +1.03% | -9.7M -10.11% | -10.8M +189.61% | -3.7M -3.82% | |
Total Nonoperating Income and Expense | -1.1M -38.17% | -1.7M -183.46% | 2.1M +143.49% | -4.7M -0.48% | |
Income before Taxes | 107.5M +200.51% | 35.8M +234.15% | -26.7M -26.25% | -36.2M -18.14% | |
Income Taxes | -82.8M -26,292.72% | 316,000 +119.23% | -1.6M -2,589.39% | 66,000 +83.33% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 190.3M +436.58% | 35.5M +241.70% | -25.0M -30.92% | -36.2M -18.06% | |
Net Income from Continuing Operations Applicable to Common | 107.5M +200.51% | 35.8M +234.15% | -26.7M -26.25% | -36.2M -18.14% | |
Basic EPS and Net Income | 5.60 +423.36% | 1.07 +238.96% | -0.77 -37.40% | -1.23 -23.12% | |
Diluted EPS and Net Income | 4.87 +382.18% | 1.01 +231.17% | -0.77 -37.40% | -1.23 -23.12% | |
Basic Weighted Average Shares | 34.0M +2.30% | 33.2M +2.19% | 32.5M +10.02% | 29.6M +7.02% | |
Diluted Weighted Average Shares | 40.5M +15.12% | 35.2M +8.30% | 32.5M +10.02% | 29.6M +7.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 488.4M +45.07% | 336.6M -14.73% | 394.8M +96.25% | 201.2M +686.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 66.9M 0.00% | |
Cash and Cash Equivalents and Short-Term Investments | 488.4M +45.07% | 336.6M -14.73% | 394.8M +47.29% | 268.1M +189.94% | |
Total Current Assets | 637.8M +28.27% | 497.2M -2.63% | 510.7M +102.40% | 252.3M +112.54% | |
Accumulated Depreciation | 66.1M +62.27% | 40.7M +91.21% | 21.3M +62.18% | 13.1M +34.86% | |
Property and Plant and Equipment and Net | 327.7M +14.58% | 286.0M +64.41% | 173.9M +804.86% | 19.2M +95.34% | |
Total Long-Term Assets | 239,000 +14.90% | 208,000 +235.48% | 62,000 -99.68% | 19.2M +320,283.33% | |
Total Assets | 1.1B +32.87% | 804.1M +13.88% | 706.0M +154.76% | 277.1M +105.46% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 10.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 89.3M +49.06% | 59.9M +9.06% | 54.9M +132.17% | 23.7M +1.82% | |
Total Long-Term Debt | 502.4M -1.36% | 509.3M +0.61% | 506.2M +762.42% | 58.7M +66.76% | |
Total Long-Term Liabilities | 3.6M -42.76% | 6.2M -18.92% | 7.7M -88.34% | 66.1M +45.62% | |
Total Liabilities | 595.3M +3.44% | 575.5M +1.17% | 568.8M +533.66% | 89.8M +33.91% | |
Retained Earnings | -277.9M -40.64% | -468.2M -7.04% | -503.7M +5.23% | -478.7M +8.19% | |
Total Stockholders Equity | 473.1M +106.95% | 228.6M +66.62% | 137.2M -26.78% | 187.4M +176.14% | |
Total Shares Outstanding | 34.3M +1.93% | 33.6M +2.90% | 32.7M +1.65% | 32.1M +15.65% | |
Cash Flow | |||||
Cash from Operating Activities | 192.8M +295.14% | 48.8M +474.60% | -13.0M -71.57% | -45.8M +58.73% | |
Capital Expenditures | 59.3M -54.33% | 129.7M -14.56% | 151.8M +1,175.28% | 11.9M +238.36% | |
Cash from Investing Activities | -59.3M -54.18% | -129.3M -33.33% | -194.0M -455.79% | 54.5M +86.26% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 16.9M -26.30% | 22.9M -94.29% | 400.4M +138.45% | 167.9M +11,955.06% | |
Financials Ratio | |||||
Gross Margin | 79.10% +33.27% | 59.36% -6.93% | 63.77% -8.69% | 69.84% -0.11% | |
Operating Margin | 29.16% +243.35% | 8.49% +171.43% | -11.89% -64.65% | -33.64% -74.18% | |
Return on Assets | 20.33% +332.75% | 4.70% +192.25% | -5.09% -71.05% | -17.59% -42.94% | |
Return on Equity | 54.24% +179.72% | 19.39% +225.73% | -15.42% -45.68% | -28.39% -44.86% | |
Revenue Growth | -15.66% -118.93% | 82.74% -47.81% | 158.53% -24.09% | 208.83% +1,058.18% | |
Current Ratio | 7.14 -13.95% | 8.30 -10.72% | 9.30 -12.82% | 10.66 +108.74% | |
Cash Ratio | 5.47 -2.68% | 5.62 -21.82% | 7.19 -15.47% | 8.50 +672.41% | |
Debt-to-Equity Ratio | 1.08 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.48 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow